USPTO 2015–2025 USPTO PatentsView US Corporation

OMNI Medsci, Inc.

USPTO PatentsView assignee record - 58 granted patents across 13 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H01S (DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

19.1

Avg claims per patent

-43%

5-year filing velocity

The verdict

OMNI holds 58 US patents across 13 technology areas, rank #5,866 of 50,000 tracked assignees.

#5,866
of 50,000 US assignees by volume: Top 34%
by Innovation Score (40.9/100): 19.1
avg claims per patent: -43%
filing velocity, last 5 yrs

Portfolio overview

OMNI Medsci, Inc. has been granted 58 US utility patents between 2015 and 2025, placing OMNI Medsci, Inc. at rank #5,866 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in H01S (DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES). As a US Corporation, OMNI Medsci, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, OMNI sits between Mattersight Corporation (58 patents, rank #5,862) and Prothena Biosciences Limited (58 patents, rank #5,870) - the closest US assignees by grant volume. The composite Innovation Score of 40.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 21 grants, compared with 37 in the 2015–2019 window, a -43% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. OMNI Medsci, Inc.'s 19.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark OMNI Medsci, Inc. against peers pursuing similar technology classes.

Mattersight

58
Nippon Thompson

58
Nortek Security &…

58
National Nail

58
Piksel

58
PTC

58
Polytec

58
Prothena Bioscien…

58
OMNI Medsci ◀

58

What this shows OMNI holds 58 patents at rank #5,866, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OMNI

By rank, the assignees closest to #5,866 in granted patent volume.

Leaders in H01S (Devices Using THE Process OF Light Amplification BY Stimu…)

Other assignees with the most granted patents in OMNI's primary technology class.

OMNI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

OMNI Medsci, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	8.6%
2016	7	12.1%
2017	5	8.6%
2018	11	19.0%
2019	9	15.5%
2020	4	6.9%
2021	5	8.6%
2022	2	3.4%
2023	3	5.2%
2024	2	3.4%
2025	5	8.6%

Which technologies does OMNI Medsci, Inc. patent most?

H01S - DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL 55

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 49

G01J - MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY 48

G01M - TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR 40

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 40

G16Z - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR 38

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 33

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 31

A61C - DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE 15

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 8

G01B - MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS 8

G02F - OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS 8

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 2

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#5,866

Across all tracked assignees

Innovation Score

40.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does OMNI Medsci, Inc. hold?

OMNI Medsci, Inc. holds 58 US granted patents filed between 2015 and 2025, spanning 13 technology areas.

What is OMNI Medsci, Inc.'s Innovation Score?

OMNI Medsci, Inc. has an Innovation Score of 40.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does OMNI Medsci, Inc. focus on?

OMNI Medsci, Inc.'s top technology area is H01S (DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL) with 55 patents. The company has filed patents in 13 CPC subclasses total.

Is OMNI Medsci, Inc.'s patent filing rate increasing or decreasing?

OMNI Medsci, Inc.'s recent filing velocity is -43% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for OMNI Medsci, Inc.'s patents?

OMNI Medsci, Inc.'s patents average 19.1 claims each. This falls within the standard range, providing solid legal coverage.

How is the OMNI Medsci, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

OMNI's 58 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - OMNI ranks #5,866 of 50,000. Top 50 holders
Most of this portfolio concentrates in H01S - see who else leads that technology area. H01S leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.